Daniel Arias
Stock Analyst at Stifel
(5.00)
# 6
Out of 4,944 analysts
157
Total ratings
56.18%
Success rate
148.01%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $48 → $40 | $34.54 | +15.81% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $13.07 | -8.19% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $90.98 | +20.91% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $54.71 | +9.67% | 11 | May 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $53 → $60 | $58.57 | +2.44% | 3 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $484.79 | +27.89% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $209.14 | +24.32% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $1.38 | +552.17% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $13.57 | +32.65% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $7.05 | -14.89% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,550 → $1,450 | $1,324.06 | +9.51% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $69.63 | -6.65% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $44.91 | +49.19% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $296.83 | +21.28% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $120.29 | +25.53% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $49.23 | -5.85% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.75 | +263.64% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $127.15 | +62.80% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $101.11 | +97.80% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $3.05 | +63.93% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $3.12 | +220.51% | 2 | May 31, 2022 |
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $34.54
Upside: +15.81%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $13.07
Upside: -8.19%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $90.98
Upside: +20.91%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $54.71
Upside: +9.67%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $53 → $60
Current: $58.57
Upside: +2.44%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $484.79
Upside: +27.89%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $209.14
Upside: +24.32%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.38
Upside: +552.17%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $13.57
Upside: +32.65%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $7.05
Upside: -14.89%
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,324.06
Upside: +9.51%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $69.63
Upside: -6.65%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $44.91
Upside: +49.19%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $296.83
Upside: +21.28%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $120.29
Upside: +25.53%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $49.23
Upside: -5.85%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.75
Upside: +263.64%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $127.15
Upside: +62.80%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $101.11
Upside: +97.80%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $3.05
Upside: +63.93%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $3.12
Upside: +220.51%